Agenus, Inc. (AGEN)
3.00
+0.04
(+1.35%)
USD |
NASDAQ |
Jun 18, 16:00
3.00
0.00 (0.00%)
After-Hours: 20:00
Agenus Accounts Payable (Quarterly) : 71.08M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 71.08M |
| December 31, 2025 | 82.99M |
| September 30, 2025 | 85.29M |
| June 30, 2025 | 74.40M |
| March 31, 2025 | 64.24M |
| December 31, 2024 | 61.47M |
| September 30, 2024 | 45.90M |
| June 30, 2024 | 50.84M |
| March 31, 2024 | 50.69M |
| December 31, 2023 | 61.45M |
| September 30, 2023 | 40.87M |
| June 30, 2023 | 52.47M |
| March 31, 2023 | 46.77M |
| December 31, 2022 | 40.94M |
| September 30, 2022 | 39.71M |
| June 30, 2022 | 41.00M |
| March 31, 2022 | 34.54M |
| December 31, 2021 | 30.49M |
| September 30, 2021 | 25.12M |
| June 30, 2021 | 19.16M |
| March 31, 2021 | 19.48M |
| December 31, 2020 | 17.02M |
| September 30, 2020 | 20.54M |
| June 30, 2020 | 20.70M |
| March 31, 2020 | 14.75M |
| Date | Value |
|---|---|
| December 31, 2019 | 13.56M |
| September 30, 2019 | 16.42M |
| June 30, 2019 | 19.05M |
| March 31, 2019 | 12.73M |
| December 31, 2018 | 13.62M |
| September 30, 2018 | 11.15M |
| June 30, 2018 | 10.23M |
| March 31, 2018 | 5.407M |
| December 31, 2017 | 8.087M |
| September 30, 2017 | 6.720M |
| June 30, 2017 | 4.572M |
| March 31, 2017 | 4.818M |
| December 31, 2016 | 5.428M |
| September 30, 2016 | 3.268M |
| June 30, 2016 | 5.022M |
| March 31, 2016 | 2.513M |
| December 31, 2015 | 4.489M |
| September 30, 2015 | 3.091M |
| June 30, 2015 | 2.662M |
| March 31, 2015 | 3.973M |
| December 31, 2014 | 1.711M |
| September 30, 2014 | 2.259M |
| June 30, 2014 | 0.9299M |
| March 31, 2014 | 1.681M |
| December 31, 2013 | 0.8347M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Iovance Biotherapeutics, Inc. | 37.45M |
| AnaptysBio, Inc. | 7.517M |
| Amarin Corp. Plc | 48.15M |
| Inovio Pharmaceuticals, Inc. | 1.988M |
| Vertex Pharmaceuticals, Inc. | 489.30M |